Search Videos and More
News
New Therapies Hold Promise for Miami Cancer Institute’s Youngest Patients
According to the American Cancer Society, cancer is now the second leading cause of death, after accidents, in children under the age of 15. But, even though roughly 10,500 U.S. children will be diagnosed with cancer this year, major treatment advances in recent decades have significantly improved pediatric cancer survival rates, experts say.
News
Breast Cancer Treatment Becomes Personal
Today’s breast cancer treatment has evolved into highly personalized care that begins at the molecular level and covers not only medical and surgical strategies, but the patient’s overall sense of wellness.
Video
Miami Cancer Institute's High-Tech High-Touch Approach
Join our experts for a panel discussion on Breast Cancer & Gynecologic Cancer, originally webcast October 21, 2021. Topics included everything from breast cancer prevention, to state-of-the-art holistic treatments, and advances in gynecologic cancer care, including robotics and therapeutics.
News
Miami Cancer Institute Becomes the First and Only APEx Accredited Proton Therapy Facility in the State of Florida
Miami Cancer Institute, part of Baptist Health South Florida, has been granted full accreditation by the ASTRO Accreditation Program for Excellence (APEx ®) for a four-year term effective August 10, 2021.
News
Questions & Answers on Rehabilitation Oncology
Rehabilitation should not be an afterthought in cancer treatment. The sooner strategies are implemented, the better the results, especially when patients have already experienced impairment, says Adrian Cristian, M.D., chief of Cancer Rehabilitation at Miami Cancer Institute.
News
Miami Cancer Institute Study Holds Promise for Patients with Inoperable Pancreatic Cancer
Michael Chuong, M.D., medical director of radiation oncology at the Institute, part of Baptist Health South Florida, presented the long-term results of inoperable pancreas cancer patients who received MR-guided stereotactic ablative radiation therapy (SABR) at the European Society for Radiotherapy and Oncology (ESTRO) 2021 conference in Madrid on August 29, 2021.
Video
Lumps and Bumps – What to Do?
Dr. Giovanni Paraliticci, orthopedic surgical oncologist at Baptist Health’s Miami Orthopedics & Sports Medicine Institute shares the latest advancements in orthopedic oncology.
News
Innovative Program at Miami Cancer Institute Gives New Meaning to ‘The Healing Arts’
The practice of medicine is often referred to as “the healing arts.” At Miami Cancer Institute, however, it’s not just the physicians doing the healing but also a group of seven professional artists.
News
Soft Tissue Masses Should Be Evaluated by Specialists
With some one in four sarcoma patients undergoing unplanned excision prior to seeking care in a specialized center, orthopedic oncologist Cecilia Belzarena, M.D., of Miami Cancer Institute, urges physicians to refer patients to a specialist prior to moving ahead with surgery.
News
Cancer Patients with HIV Have More Options
Cancer patients with HIV often requires complex care. Miami Cancer Institute, now a member of the AIDS Malignancy Consortium (AMC), recently opened an HIV/Cancer Clinic, providing better access to new clinical trials as well as coordinated, multidisciplinary care in one location.
News
Chemoprevention: Helping Patients Understand the Benefits
With chemoprevention medications proven to decrease breast cancer risk by 50 to 60 percent, Miami Cancer Institute experts are urging those with certain risk factors to take part in the Making Informed Choices on Incorporating Chemoprevention into Care (MiCHOICE) trial.
News
Miami Cancer Institute Expert Co-Leads Research Effort Using Advanced Multi-omics Platform that Predicts Superior Overall Survival and Disease-Free Survival for Brain Cancer Patients
Manmeet Ahluwalia, M.D., M.B.A., deputy director, chief scientific officer and chief of solid tumor medical oncology at Miami Cancer Institute, and co-principal investigators of the trial, was featured in the 2021 ASCO Annual Meeting during the Central Nervous System Tumors Track